Methods to assess the likelihood of dysplasia or esophageal adenocarcinoma
A technology for dysplasia and esophageal adenocarcinoma, applied in biochemical equipment and methods, microbial determination/inspection, etc., can solve the problem of not providing biomarkers, and achieve the effect of overcoming sampling bias
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0059] We taught that DNA methylation can detect insignificant dysplasia and early tumors in Barrett's esophagus, DNA methylation detects dysplasia / cancer.
[0060] Changes in the methylation of specific genes may be ideal biomarkers since physiological inactivation of one allelic copy already occurs in females by imprinting and by X-inactivation.
[0061] We performed DNA methylation screens of BE and EAC samples using the array to determine candidate biomarkers. We analyzed imprinted and X-chromosome genes separately and purposefully separated males from females to allow meaningful conclusions to be drawn. We performed robust internal and external validation using pyrosequencing, which is currently the gold standard in DNA methylation analysis, and from which a panel of biomarkers could be determined to distinguish dysplastic from non-dysplastic BE. Finally, we validated the biomarker panel with real-time analysis in a prospective cohort to stratify BE patients into low, in...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com